Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1987 1
1988 1
1991 1
1992 1
1996 1
1997 1
1998 2
1999 1
2000 2
2001 2
2002 4
2003 9
2004 2
2005 8
2006 6
2007 6
2008 1
2009 10
2010 5
2011 8
2012 9
2013 12
2014 13
2015 8
2016 7
2017 11
2018 7
2019 3
2021 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Results by year

Filters applied: . Clear all
Page 1
Naltrexone: A Pan-Addiction Treatment?
Aboujaoude E, Salame WO. Aboujaoude E, et al. CNS Drugs. 2016 Aug;30(8):719-33. doi: 10.1007/s40263-016-0373-0. CNS Drugs. 2016. PMID: 27401883 Review.
The goal of this review is to provide an evidence-based assessment of the therapeutic role of the opioid antagonist naltrexone across the addiction spectrum-substance-based and behavioral. The PubMed database was searched for randomized, placebo-controlled clinical trials …
The goal of this review is to provide an evidence-based assessment of the therapeutic role of the opioid antagonist naltrexone across …
Gambling disorder, DSM-5 criteria and symptom severity.
Grant JE, Odlaug BL, Chamberlain SR. Grant JE, et al. Compr Psychiatry. 2017 May;75:1-5. doi: 10.1016/j.comppsych.2017.02.006. Epub 2017 Feb 21. Compr Psychiatry. 2017. PMID: 28260605 Free PMC article.
INTRODUCTION: Gambling disorder (GD) is a prevalent psychiatric condition whose severity is typically defined by the number of DSM-5 criteria met out of a maximum of nine. ...The moderate and severe groups did not differ significantly on these measures, however. The Yale-B …
INTRODUCTION: Gambling disorder (GD) is a prevalent psychiatric condition whose severity is typically defined by the number of DSM-5 …
Treatment of pathological gambling.
Leung KS, Cottler LB. Leung KS, et al. Curr Opin Psychiatry. 2009 Jan;22(1):69-74. doi: 10.1097/YCO.0b013e32831575d9. Curr Opin Psychiatry. 2009. PMID: 19122538 Review.
PURPOSE OF REVIEW: This paper highlights the development of pharmacological and nonpharmacological treatments for pathological gambling and is based on a review of the literature published in the past 12 months. RECENT FINDINGS: The efficacy of naltrexone treatment …
PURPOSE OF REVIEW: This paper highlights the development of pharmacological and nonpharmacological treatments for pathological gam …
Evidence-based pharmacological treatment of substance use disorders and pathological gambling.
van den Brink W. van den Brink W. Curr Drug Abuse Rev. 2012 Mar;5(1):3-31. doi: 10.2174/1874473711205010003. Curr Drug Abuse Rev. 2012. PMID: 22126708 Review.
This review summarizes our current knowledge of the pharmacological treatment of substance use disorders and pathological gambling using data mainly from randomized controlled trials and meta-analyses regarding these randomized controlled trials. The review is restr …
This review summarizes our current knowledge of the pharmacological treatment of substance use disorders and pathological gambling …
Pharmacological treatment of adolescent pathological gambling.
Grant JE, Potenza MN. Grant JE, et al. Int J Adolesc Med Health. 2010 Jan-Mar;22(1):129-38. Int J Adolesc Med Health. 2010. PMID: 20491422 Free PMC article. Review.
There are, however, no pharmacological treatments for pathological gambling in children, adolescents, or adults that are currently approved by the United States Food and Drug Administration (FDA). Additionally, no studies have investigated directly the safety and ef …
There are, however, no pharmacological treatments for pathological gambling in children, adolescents, or adults that are curre …
Glutamatergic medications for the treatment of drug and behavioral addictions.
Olive MF, Cleva RM, Kalivas PW, Malcolm RJ. Olive MF, et al. Pharmacol Biochem Behav. 2012 Feb;100(4):801-10. doi: 10.1016/j.pbb.2011.04.015. Epub 2011 Apr 22. Pharmacol Biochem Behav. 2012. PMID: 21536062 Free PMC article. Review.
However, substantial evidence has accumulated indicating that ligands acting on glutamatergic transmission are also of potential utility in the treatment of drug addiction, as well as various behavioral addictions such as pathological gambling. The purpose of this r …
However, substantial evidence has accumulated indicating that ligands acting on glutamatergic transmission are also of potential utility in …
Phenomenology and treatment of behavioural addictions.
Grant JE, Schreiber LR, Odlaug BL. Grant JE, et al. Can J Psychiatry. 2013 May;58(5):252-9. doi: 10.1177/070674371305800502. Can J Psychiatry. 2013. PMID: 23756285 Review.
Behavioural addictions share characteristics with substance and alcohol abuse, and in areas such as natural history, phenomenology, and adverse consequences. Behavioural addictions include pathological gambling, kleptomania, pyromania, compulsive buying, compulsive …
Behavioural addictions share characteristics with substance and alcohol abuse, and in areas such as natural history, phenomenology, and adve …
Treatment of Pramipexole-Induced Problematic Sexual Behaviors.
Murphy L, Ly T, DiMario K, Mihowich T, Fedoroff JP. Murphy L, et al. Prim Care Companion CNS Disord. 2021 Feb 18;23(1):20br02663. doi: 10.4088/PCC.20br02663. Prim Care Companion CNS Disord. 2021. PMID: 34000142 Free article.
Pramipexole is a dopaminergic pharmacologic agent with reported adverse effects that include hypersexuality, shift in sexual interests, pathological gambling, compulsive shopping, and binge eating. Pramipexole is indicated in the treatment of Parkinson's disease and …
Pramipexole is a dopaminergic pharmacologic agent with reported adverse effects that include hypersexuality, shift in sexual interests, p …
Psychopharmacological treatment in pathological gambling: a critical review.
Achab S, Khazaal Y. Achab S, et al. Curr Pharm Des. 2011;17(14):1389-95. doi: 10.2174/138161211796150774. Curr Pharm Des. 2011. PMID: 21524264 Review.
Given the rates of pathological gambling and its impact on affected individuals and their relatives, effective treatments are needed. There are, however, no approved pharmacological treatments for pathological gambling. This paper describes the develop …
Given the rates of pathological gambling and its impact on affected individuals and their relatives, effective treatments are …
Prevalence, assessment, and treatment of pathological gambling: a review.
Petry NM, Armentano C. Petry NM, et al. Psychiatr Serv. 1999 Aug;50(8):1021-7. doi: 10.1176/ps.50.8.1021. Psychiatr Serv. 1999. PMID: 10445649 Review.
OBJECTIVE: Although pathological gambling is an increasing problem, many mental health providers are unfamiliar with its diagnosis and treatment. ...The most commonly used assessment instrument is the DSM-based, 20-item South Oaks Gambling Screen. There is no …
OBJECTIVE: Although pathological gambling is an increasing problem, many mental health providers are unfamiliar with its diagn …
133 results